2nd Quarter - Report
ARNOLD & PORTER KAYE SCHOLER LLP for ADAPTIVE BIOTECHNOLOGIES
Client
Income
$60,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to lab analysis and review of diagnostics and lab developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023 (H.R. 2369).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTINE BLACKWOOD | — |
| CASEY BROUHARD | — |
| KATIE BROWN | — |
| PETER ERIC DUYSHART | — |
| BOBBY MCMILLIN | — |
| PARI MODY | — |
| EUGENIA PIERSON | — |
Budget/Appropriations BUD
Issues related to supporting research pertaining to Minimal Residual Disease (MRD) testing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTINE BLACKWOOD | — |
| CASEY BROUHARD | — |
| KATIE BROWN | — |
| PETER ERIC DUYSHART | — |
| BOBBY MCMILLIN | — |
| PARI MODY | — |
| EUGENIA PIERSON | — |
Medicare/Medicaid MMM
Issues related to Medicare coverage of multi-cancer early detection screening tests, including the Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 2407 & S. 2085).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTINE BLACKWOOD | — |
| CASEY BROUHARD | — |
| KATIE BROWN | — |
| PETER ERIC DUYSHART | — |
| BOBBY MCMILLIN | — |
| PARI MODY | — |
| EUGENIA PIERSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.